4//SEC Filing
Flowers Cynthia Louise 4
Accession 0001562180-23-005271
CIK 0001560241other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:07 PM ET
Size
11.6 KB
Accession
0001562180-23-005271
Insider Transaction Report
Form 4
Flowers Cynthia Louise
Director
Transactions
- Award
Common Stock
2023-06-15+10,000→ 25,889 total - Award
Stock Options (Right to Buy)
2023-06-15+30,000→ 30,000 totalExercise: $2.83Exp: 2033-06-15→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors. The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 5,889 shares of common stock; (ii) 10,000 RSUs from award granted on June 23, 2022; and (iii) 10,000 RSUs from award granted on June 15, 2023.
- [F4]The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001741455
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:07 PM ET
- Size
- 11.6 KB